toosendanin has been researched along with Cancer of Stomach in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Y; Li, S; Liu, C; Pan, Y; Shao, S; Zhang, W; Zhang, Z; Zhu, S | 1 |
| Chen, XY; Hou, LD; Huang, YX; Liu, H; Wang, G; Zhang, J; Zhang, R; Zhu, JS | 1 |
| Liu, H; Peng, J; Wang, H; Wen, C; Wu, X; Zhou, Q | 1 |
3 other study(ies) available for toosendanin and Cancer of Stomach
| Article | Year |
|---|---|
Toosendanin induces apoptosis of MKN‑45 human gastric cancer cells partly through miR‑23a‑3p‑mediated downregulation of BCL2.
Topics: Antineoplastic Agents, Phytogenic; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Drugs, Chinese Herbal; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Proto-Oncogene Proteins c-bcl-2; Stomach Neoplasms | 2020 |
Toosendanin suppresses oncogenic phenotypes of human gastric carcinoma SGC‑7901 cells partly via miR‑200a‑mediated downregulation of β-catenin pathway.
Topics: Animals; Apoptosis; beta Catenin; Carcinoma; Cell Line, Tumor; Cell Proliferation; Drugs, Chinese Herbal; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Mice; MicroRNAs; Neoplasm Invasiveness; Neoplasm Metastasis; Stomach Neoplasms; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2017 |
Toosendanin induces caspase-dependent apoptosis through the p38 MAPK pathway in human gastric cancer cells.
Topics: Apoptosis; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; G1 Phase Cell Cycle Checkpoints; Humans; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Stomach Neoplasms | 2018 |